Literature DB >> 8839871

Increased rotational mobility and extractability of band 3 from protein 4.2-deficient erythrocyte membranes: evidence of a role for protein 4.2 in strengthening the band 3-cytoskeleton linkage.

A C Rybicki1, R S Schwartz, E J Hustedt, C E Cobb.   

Abstract

Band 3 (anion-exchange protein 1-[AE1]) is the major integral membrane protein of human erythrocytes and links the membrane to the underlying cytoskeleton via high-affinity binding to ankyrin. It is unclear whether other cytoskeletal proteins participate in strengthening the ankyrin-band 3 linkage, but a putative role for protein 4.2 (P4.2) has been proposed based on the increased osmotic fragility and spherocytic morphology of P4.2-deficient red blood cells (RBCs). The present study was designed to investigate the hypothesis that P4.2 has a direct role in strengthening the band 3-cytoskeleton linkage in human RBCs, by measuring independent features of this interaction in normal and P4.2-deficient RBCs. The features examined were the rotational mobility of band 3 assayed by time-resolved phosphorescence emission anisotropy (TPA), and the extractability of band 3 by octyl-beta-glucoside, the latter being a nonionic detergent that selectively extracts only band 3 that is not anchored to the cytoskeleton. We find that the amplitude of the most rapidly rotating population of band 3 (correlation time, approximately 30 to 60 microseconds) is increased 81% and 67% in P4.2-deficient ghosts (P4.2NIPPON and band 3MONTEFIORE, respectively) compared with control ghosts. The amplitude of the intermediate speed rotating population of band 3 (correlation time, approximately 200 to 500 microseconds) is increased 23% and 8% in P4.2-deficient ghosts (P4.2NIPPON and band 3MONTEFIORE, respectively) compared with control ghosts, at the expense of the slowly rotating component (correlation time, approximately 2,000 to 3,000 microseconds, amplitude decreased 43% and 39% in P4.2NIPPON and band 3MONTEFIORE, respectively) and immobile component (immobile on this experimental time scale; amplitude decreased 26% and 10% in P4.2NIPPON and band 3MONTEFIORE, respectively) of band 3. These results demonstrate that P4.2 deficiency partially removes band 3 rotational constraints, ie, it increases band 3 rotational mobility. The nonionic detergent octyl-beta-glucoside, which does not disturb band 3-cytoskeleton associations, ie, it extracts only band 3 that is not attached to the cytoskeleton, extracted 30% and 61% more band 3 from P4.2NIPPON and band 3MONTEFIORE ghost membranes, respectively, compared with control ghosts. The octyl-beta-glucoside ghost extracts from both P4.2-deficient phenotypes were enriched in band 3 oligomeric species (tetramers, higher-order oligomers, and aggregates) compared with controls. Since band 3 oligomers selectively associate with the cytoskeleton, these results are consistent with a weakened band 3-cytoskeleton linkage in P4.2-deficient RBC membranes. P4.2 deficiency does not affect band 3 anion transport activity, since uptake of radiolabeled sulfate was similar for control and P4.2-deficient RBCs. Thus, we propose that P4.2 directly participates in strengthening the band 3-cytoskeleton linkage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839871

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Flexibility of the cytoplasmic domain of the anion exchange protein, band 3, in human erythrocytes.

Authors:  S M Blackman; E J Hustedt; C E Cobb; A H Beth
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Mapping of a palmitoylatable band 3-binding domain of human erythrocyte membrane protein 4.2.

Authors:  R Bhattacharyya; A K Das; P K Moitra; B Pal; I Mandal; J Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Temporal sequence of major biochemical events during blood bank storage of packed red blood cells.

Authors:  Brad S Karon; Camille M van Buskirk; Elizabeth A Jaben; James D Hoyer; David D Thomas
Journal:  Blood Transfus       Date:  2012-03-28       Impact factor: 3.443

4.  Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (-) cells (mutations Chartres 1 and 2).

Authors:  Emile van den Akker; Timothy J Satchwell; Stephanie Pellegrin; Joanna F Flatt; Michel Maigre; Geoff Daniels; Jean Delaunay; Lesley J Bruce; Ashley M Toye
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

5.  Associations of protein 4.2 with band 3 and ankyrin.

Authors:  Yang Su; Yu Ding; Ming Jiang; Weihua Jiang; Xiaojian Hu; Zhihong Zhang
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

6.  Oligomeric state of human erythrocyte band 3 measured by fluorescence resonance energy homotransfer.

Authors:  S M Blackman; D W Piston; A H Beth
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

7.  Role of CD47 and Signal Regulatory Protein Alpha (SIRPα) in Regulating the Clearance of Viable or Aged Blood Cells.

Authors:  Oldenborg Per-Arne
Journal:  Transfus Med Hemother       Date:  2012-09-17       Impact factor: 3.747

8.  Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant.

Authors:  Gerhard Rank; Rosemary Sutton; Vikki Marshall; Rachel J Lundie; Jacinta Caddy; Tony Romeo; Kate Fernandez; Matthew P McCormack; Brian M Cooke; Simon J Foote; Brendan S Crabb; David J Curtis; Douglas J Hilton; Benjamin T Kile; Stephen M Jane
Journal:  Blood       Date:  2009-01-28       Impact factor: 22.113

9.  Changes in Band 3 oligomeric state precede cell membrane phospholipid loss during blood bank storage of red blood cells.

Authors:  Brad S Karon; James D Hoyer; James R Stubbs; David D Thomas
Journal:  Transfusion       Date:  2009-03-23       Impact factor: 3.157

10.  Fluorescence assay of the interaction between hemoglobin and the cytoplasmic domain of erythrocyte membrane band 3.

Authors:  Martiana F Sega; Haiyan Chu; John A Christian; Philip S Low
Journal:  Blood Cells Mol Dis       Date:  2015-07-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.